ORMP
ORAMED PHARMACEUTICALS INC.
NASDAQ · Healthcare · Biotechnology · US
$4.07
+1.83%Forward multiples
Based on analyst estimates
- P/E forward
- 11.01x
- P/E 2026E
- 0.92x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.96x
- PEG TTM
- —
- Price / book
- 0.53x
- Price / sales
- —
- Price / cash flow
- -30.43x
Enterprise value
- Enterprise value
- $119.6M
- EV / sales
- —
- EV / EBITDA
- 0.79x
- EV / EBIT
- -8.23x
- Market cap
- $169.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026